Articles

IDT just reported results for the third quarter of 2024. More

Undervalued cannabis stocks may be some of the most controversial trades on the market. But they’ve also proven themselves profitable. More

If you have the patience and the ability to take a little risk, consider these three biotech stocks to buy since they can really pay off. More

Novavax continues to march higher in its recovery efforts, with its latest vaccine announcement lifting NVAX stock. More

For investors seeking hyper-growth stocks to buy in this current environment, here are three I think are worth researching right now. More

BlackRock and Citadel are backing the launch of the Texas Stock Exchange. Here's what investors need to know. More

Recent strength in U.S. Treasurys as junk bonds falter suggests that credit spreads are widening. Why that is bad news for Wall Street. More

Subscriber Sign in